Vaccination in the elderly: an immunological perspective

被引：146

作者：

Chen, Wilbur H. ^{[1
]}

Kozlovsky, Bernard F. ^{[2
]}

Effros, Rita B. ^{[3
]}

Grubeck-Loebenstein, Beatrix ^{[4
]}

Edelman, Robert ^{[1
]}

Sztein, Marcelo B. ^{[1
]}

机构：

[1] Univ Maryland, Ctr Vaccine Dev, Sch Med, Baltimore, MD 21201 USA

[2] Univ Maryland, Dept Epidemiol & Prevent Med, Sch Med, Baltimore, MD 21201 USA

[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[4] Austrian Acad Sci, Inst Biomed Aging Res, A-6020 Innsbruck, Austria

来源：

TRENDS IN IMMUNOLOGY | 2009年 / 30卷 / 07期

基金：

奥地利科学基金会; 美国国家卫生研究院;

关键词：

HEPATITIS-B-VACCINE; HUMORAL IMMUNE-RESPONSE; T-CELL RESPONSES; INFLUENZA VACCINATION; REPLICATIVE SENESCENCE; ANTIBODY-RESPONSE; SURFACE-ANTIGEN; PNEUMOCOCCAL POLYSACCHARIDE; CYTOMEGALOVIRUS-INFECTION; CONJUGATE VACCINE;

D O I：

10.1016/j.it.2009.05.002

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Successful vaccination of the elderly against important infectious pathogens that cause high morbidity and mortality represents a growing public health priority. Building on the theme of aging and immunosenescence, we review mechanisms of human immunosenescence and the immune response to currently licensed vaccines. We discuss the difficulties in identifying the risk factors that, in addition to aging, cause immunosenescence and address the relative paucity of vaccine studies in the elderly. We conclude that vaccine responses are blunted in the elderly compared with that of healthy young adults. However, it is also clear that our understanding of the mechanisms underlying immunosenescence is limited and much remains to be learned to improve the effectiveness of next generation vaccines.

引用

页码：351 / 359

页数：9

共 113 条

[1] Antibody protection to diphtheria in geriatric patients: Need for ED compliance with immunization guidelines [J].

Alagappan, K ;

Rennie, W ;

Kwiatkowski, T ;

Narang, V .

ANNALS OF EMERGENCY MEDICINE, 1997, 30 (04) :455-458

[2]

ALPER CA, 1995, EXP CLIN IMMUNOGENET, V12, P171

[3]

Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1

[4] HETEROGENEITY OF IMMUNE RESPONSIVENESS IN HEALTHY ELDERLY SUBJECTS [J].

BARCELLINI, W ;

BORGHI, MO ;

SGUOTTI, C ;

PALMIERI, R ;

FRASCA, D ;

MERONI, PL ;

DORIA, G ;

ZANUSSI, C .

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 47 (02) :142-151

[5] Yellow fever: Epidemiology and prevention [J].

Barnett, Elizabeth D. .

CLINICAL INFECTIOUS DISEASES, 2007, 44 (06) :850-856

[6] ANTIBODY INDUCTION BY INFLUENZA VACCINES IN THE ELDERLY - A REVIEW OF THE LITERATURE [J].

BEYER, WEP ;

PALACHE, AM ;

BALJET, M ;

MASUREL, N .

VACCINE, 1989, 7 (05) :385-394

[7] Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age [J].

Blatter, Mark ;

Friedland, Leonard R. ;

Weston, Wayde M. ;

Li, Ping ;

Howe, Barbara .

VACCINE, 2009, 27 (05) :765-772

[8] Premature Aging of T cells Is Associated With Faster HIV-1 Disease Progression [J].

Cao, Weiwei ;

Jamieson, Beth D. ;

Hultin, Lance E. ;

Hultin, Patricia M. ;

Effros, Rita B. ;

Detels, Roger .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (02) :137-147

[9] Immune function and vaccine responses in healthy advanced elderly patients [J].

Carson, PJ ;

Nichol, KL ;

O'Brien, J ;

Hilo, P ;

Janoff, EN .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (13) :2017-2024

[10] Clinical relevance of age-related immune dysfunction [J].

Castle, SC .

CLINICAL INFECTIOUS DISEASES, 2000, 31 (02) :578-585

← 1 2 3 4 5 6 7 8 9 10 →